Pengaruh Propolis Terhadap Il-6 Pada Diabetes Melitus Tipe 2: A Literature Review

Nazula Rahma Shafriani


Type-2 diabetes is a metabolic disease characterized by an increase in blood sugar levels due to decreased insulin secretion by pancreatic beta cells, or inappropriate insulin action. The pathophysiology of type-2 diabetes is related to inflammatory mechanisms caused by an increase in proinflammatory cytokines such as IL-6. Propolis has an anti-inflammatory role that can influence type 2 diabetes. To determine the effect of propolis as an anti-inflammatory to the IL-6 cytokines in type 2 Diabetes Mellitus A Literature review by searching electronic databases on Pubmed, ProQuest, and Google Scholar with the keywords "propolis or bee propolis and IL-6 levels or interleukin-6 levels and diabetes type-2 or type-2 diabetes" published in 2010-2020. Based on the search results, 9 journals were found. These articles consist of 5 experimental articles and 4 RCT articles. Five databases reported a decrease in IL-6 levels and three journals stated that there was an increase in IL-6 levels in the type-2 diabetes group after being given propolis. One journal reported no significant difference. Variations in propolis administration and time in IL-6 measurements affected the tendency to decrease IL-6 levels in type 2 diabetes patients. The active components in propolis were influenced by differences in plant resources, collection season, bee species, and solvents used in the extraction. IL-6 levels in the type-2 diabetes group tended to decrease after propolis administration compared to the type-2 diabetes group without propolis administration. IL-6 levels in the type-2 diabetes group increased after propolis administration because IL-6 helps improve chronic inflammation associated with type-2 diabetes.


Propolis; IL-6; Type-2 Diabetes


  1. Kementerian Kesehatan RI, 2013. Profil Kesehatan Indonesia 2010. Jakarta: Kemenkes RI.
  2. Aritrina P, Marzuki A, Mangerangi F. Analisis Kadar Low Density Lipoprotein sebagai Faktor Risiko Komplikasi pada Pasien Diabetes Melitus Tipe 2. Jurnal Universitas Halu Oleo. 2016; 4(1) 291-296.
  3. Departemen Kesehatan RI, 2008. Pedoman Pengendalian Diabetes Melitus dan Penyakit Metabolik.
  4. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004; 25:4–7.
  5. Frances D.E, Ingaramo P.I, Ronco M.T, Carnovale C.E. Diabetes, an inflammatory process : Oxidative Stress and TNF-alpha involved in hepatic complication. J. Biomedical Science and Engineering. 2013; 6: 645-653.
  6. Rifa’i M, Widodo N. Significance of propolis administration for homeostasis of CD4+CD25+ immunoregulatory T cells controlling hyperglycemia. Spingerplus. 2014; 3: 526.
  7. Rifa’i, M. Studies on the therapeutic effect of propolis in streptozotocin-induced diabetic mice. The 7th International Conference on Global Resource Conservation. AIP Conference Proceedings. 2017, 1844(1): 1-6.
  8. Ningsih F.N, Rifa’i M. Propolis Action in Controlling Activated T Cell Producing TNF-alfa and IFN gamma in Diabetic Mice. Turkish Journal of Immunology. 201; 5(2): 36-44.
  9. Boddupalli A, Kumanan R, Elumalai A, Eswaraiah M.C, Veldi N, & Pendem N. A Twelve-Monthly Review on AntiDiabetic Plants: Jan-Dec, 2011. International Research Journal of Pharmacy. 2012; 3: 77–80.
  10. Shaw J.E, Sicree R.A, Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice. 2010; 87: 4-14.
  11. Josten S, Mutmainnah, Hardjoeno. Profil Lipid Penderita Diabetes Mellitus Tipe 2. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2006; 13(1): 20-22.
  12. Fukuda T, Fukui M, Tanaka M, Senmaru T, Iwase H, Yamazaki M, Aoi W, Inui T, Nakamura N, Marunaka Y. Effect of Brazilian green propolis in patients with type 2 diabetes: A double-blind randomized placebo-controlled study. Biomedical reports. 2015; 3: 355-360
  13. Zakerkish M, Jenabi M, Zaeemzadeh N, Hemmati, A.A, Neisi N. The Effect of Iranian Propolis on Glucose Metabolism, Lipid Profile, Insulin Resistance, Renal Function and Inflammatory Biomarkers in Patients with Type 2 Diabetes Mellitus: A Randomized Double-Blind Clinical Trial. Scientific Reports. 2019; 9(7289): 1-12.
  14. Y. Yu, Y. Si, G. Song, T. Luo, J. Wang, and S. Qin, “Ethanolic extract of propolis promotes reverse cholesterol transport and the expression of ATP-binding cassette transporter A1 and G1 in mice,” Lipids. 2011; 46(9): 805–811.
  15. Mujica V, Orrego R, Perez J, Romero P, Ovalle P, Zuniga-Hernandez J, Arredondo M, Leiva E. The Role of Propolis in Oxidative Stress and Lipid Metabolism: A Randomized Controlled Trial. Evidence-Based Complementary and Alternative Medicine. 2017; 1-11.
  16. Sutjahjo A. Adiponektin High Molecular Weight Dan Kekakuan Vaskular Di Penyakit Diabetes Melitus Tipe 2 Terkait Gabungan Glimepiride Metformin Dosis Tetap. Indonesian Journal of Clinical Pathology and Medical Laboratory. 2015; 21(2): 120–124.
  17. Singh B, Saxena A. Surrogate Markers of Insulin Resistance: A Review. World J Diabetes. 2010; 1:36-47.
  18. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim. Biophys. Acta. 2011; 1813: 878–888.
  19. Gao W, Pu L, Wei J, Yao Z, Wang Y, Shi T, Jiao C, Guo C. Serum Antioxidant Parameters are Significantly Increased in Patients with Type 2 Diabetes Mellitus after Consumption of Chinese Propolis: A Randomized Controlled Trial Based on Fasting Serum Glucose Level. Diabetes Ther. 2018; 9: 101-111.
  20. Zhao L, Pu L, Wei J, Li J, Wu J, Xin Z, Gao W, Guo C. Brazilian Green Propolis Improves Antioxidant Function in Patients with Type 2 Diabetes Mellitus. International Journal of Environmental Research and Public Health. 2016; 13(498): 1-9
  21. Matsui T, Ebuchi S, Fujise T, Abesundara K. J. M, Doi S, Yamada H, Matsumoto K. Strong antihyperglycemic efects of water-souluble fraction of brazillian propolis and its bioactive
    constituent, 3,4,5-tri-o-cafeoylquinic acid. Biol Pharm ull. 2004; 27(11): 1797–1803.
  22. Sameni H.R, Ramhormozi P, Bandegi A.R, Taherian A.A, Mirmohammadkhani M, Safari M. Efects of ethanol extract of propolis on histopathological changes and anti-oxidant defense of kidney in a rat model for type 1 diabetes mellitus. J Diabetes Investig. 2016; 7(4): 506–513.
  23. Al Hariri M.T. Propolis and its direct and indirect hypoglycemic effect. Journal of Family and Community Medicine. 2011; 18 (3): 152-154.
  24. Zhang H, Wang G, Beta T, Dong J. Inhibitory properties of aqueous ethanol extracts of propolis on alpha-glucosidase. Evid
    Based Complement Alternat Med
    . 2015; 1-7.
  25. Wang, K., Ping, S., Huang, S., Hu, L., Xuan, H., Zhang C, Hu F. Molecular Mechanism Underlaying the In Vitro Anti-Inflammatory Effects of a Flavonoid-Rich Ethanol Extract from Chinese Propolis (Poplar Type). Evidence-Based Complementary and Alternative Medicine. 2013; 1-11.
  26. Egawa T, Ohno Y, Yokoyama S, Yokokawa T, Tsuda S, Goto K, Hayashi T. The Protective Effect of Brazilian Propolis against Glycation Stress in Mouse Skeletal Muscle. Foods. 2019; 8(439): 1-13.
  27. Bankova V. Chemical diversity of propolis and the problem of standardization. Journal of Ethnopharmacology. 2005; 100(1): 114–117.
  28. Popova M.P, Bankova V.S, Bogdanov S, Tsvetkova I, Naydenski C, Marcazzan G.L, Sabatini A.G. Chemical characteristics of poplar type propolis of different geographic origin. Apidologie. 2007; 38 (3): 306–311.
  29. Washio K, Kobayashi M, Saito N, Amagasa M, Kitamura H. Propolis Ethanol Extract Stimulates Cytokine and Chemokine Production through NF-Kb Activation in C2C12 Myoblast. Evidence-Based Complementary and Alternative Medicine. 2015; 1-7.
  30. Paviani L.C, Dariva C, Marcucci M.C, and Cabral F.A. Super critical carbon dioxide selectivity to fractionate phenolic compounds from the dry ethanolic extract of propolis. J Food Process Eng. 2010; 33: 15-27
  31. Gardana C, Simonetti P. Evaluation of allergens in propolis by ultra-performance liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2011; 25: 1675-1682.
  32. Bachiega T.F, Orsatti C.L, Pagliarone AC, Sforcin, J.M. The effects of propolis and its isolated compounds on cytokine production by murine macrophages. Phytother. Res. 26: 1308–1313.
  33. Margetic, S. Inflammation and haemostasis. 2012. Biochem. Med. 2012; 22(1): 49–62.
  34. Scherer T, Lindtner C, O’hare J, Hackl M, Zielinski E, Freudenthaler A, Baumgartner-Parzer S, Tödter K, Heeren J, Krššák M, Scheja L, Fürnsinn C, Buettner C. Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain. Diabetes. 2016; 65:1511-1520.
  35. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiological Research. 2001; 50(6): 537–546.
  36. Gonzalez-Quintela A, Alende R, Gude F, Campos L.M, Fernandez-Merino C, Vidal C. Serum levels of immunoglobulins (IgG, IgA, IgM) in a general adult population and their relationship with alcohol consumption, smoking and common metabolic abnormalities. Clinical and Experimental Immunology. 2008; 151(1): 42–50.
  37. El Rabey H.A, Al-Seeni M.N, Bakhashwain A.S. The Antidiabetic Activity of Nigella sativa and Propolis on Streptozotocin-Induced Diabetes and Diabetic Nephropathy in Male Rats. Evidence-Based Complementary and Alternative Medicine. 2017; 1-14.
  38. Moustafa B.G, Rahman A.M.A. Evaluation of The Role of Propolis and Myrrah in Curing Hepatorenal Toxicity Induced By Diabetes in Mice. The Egyptian Society of Experimental Biology. 2016; 12 (1): 93-103.

Full Text: PDF

DOI: 10.30595/hmj.v4i3.9476


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

ISSN: 2620-567X